Humana (HUM)

192.09
+4.88 (2.61%)
NYSE · Last Trade: Feb 3rd, 1:11 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close187.20
Open187.04
Bid191.94
Ask192.23
Day's Range186.95 - 192.31
52 Week Range186.00 - 315.35
Volume1,080,367
Market Cap24.68B
PE Ratio (TTM)17.97
EPS (TTM)10.7
Dividend & Yield3.540 (1.84%)
1 Month Average Volume2,162,424

Chart

About Humana (HUM)

Humana is a leading health insurance company that provides a wide range of health and wellness solutions to individuals, families, and employers. The organization offers Medicare Advantage plans, Medicaid services, and individual health insurance policies, focusing on enhancing the health and well-being of its members. Additionally, Humana invests in technology and innovative care management services, aiming to improve healthcare delivery and patient outcomes. The company is dedicated to integrating medical and wellness services to create a comprehensive approach to health management for its customers. Read More

News & Press Releases

Humana Stock Slips Premarket After Hitting 9-Year Low: Morgan Stanley Sees Medicare Advantage Risk In 2027stocktwits.com
Via Stocktwits · February 3, 2026
Nasdaq, S&P 500 Futures Edge Higher Ahead Of Earnings Rush: Why PLTR, AMZN, TSLA, WULF Are On Traders' Radar Todaystocktwits.com
Retail sentiment on major ETFs such as SPY and QQQ remains mixed on Stocktwits.
Via Stocktwits · February 3, 2026
UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The Start—PBM 'Spread Pricing' Comes Under Firebenzinga.com
Trump's Medicare rate cap and a new "radical" PBM transparency rule hit UnitedHealth, CVS, and Humana. See why health stocks are tumbling.
Via Benzinga · February 3, 2026
1 S&P 500 Stock for Long-Term Investors and 2 We Brush Off
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Via StockStory · February 2, 2026
These S&P500 stocks are moving in today's sessionchartmill.com
Via Chartmill · February 2, 2026
What Analysts Are Saying About Humana Stockbenzinga.com
Via Benzinga · February 2, 2026
Discover the top S&P500 movers in Monday's pre-market session.chartmill.com
Via Chartmill · February 2, 2026
Humana (HUM): Buy, Sell, or Hold Post Q3 Earnings?
What a brutal six months it’s been for Humana. The stock has dropped 20.9% and now trades at $195.56, rattling many shareholders. This might have investors contemplating their next move.
Via StockStory · February 1, 2026
Should You Buy the Dip in These 2 Dividend Stocks?
Tighter Medicare Advantage payment rates are testing two established health insurers, with CVS Health offering a safer dividend entry at 28% upside and 3% yield while Humana's 36% year-over-year decline creates a riskier but potentially stronger boun...
Via Barchart.com · January 30, 2026
S&P 500 Smashes Historic 7,000 Milestone Amidst AI Super-Cycle and Policy Seismic Shifts
In a historic display of market resilience and technological optimism, the S&P 500 index officially crossed the 7,000-point threshold on January 28, 2026. This monumental achievement marks a new era for Wall Street, coming just fourteen months after the index first touched 6,000 in late 2024. The
Via MarketMinute · January 30, 2026
Stocks making big moves this week: Lockheed Martin, Texas Instruments, Western Digital, Humana, and Brown & Brown
Check out the companies making headlines this week:
Via StockStory · January 30, 2026
UnitedHealth Rival Humana Tops Valuation Metric As 26% YTD Plunge Creates Entry Point Amid Trump's Proposed Medicare Ratesbenzinga.com
Humana's Value Score hits 86.97 as a 26% YTD drop and Trump's Medicare proposal create a high-value entry point despite sector headwinds.
Via Benzinga · January 30, 2026
1 Healthcare Stock to Own for Decades and 2 We Question
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 17.4% gain over the past six months, beating the S&P 500 by 7.8 percentage points.
Via StockStory · January 29, 2026
These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip?
Abbott, Roper, and Humana are three blue-chip oversold stocks with significant upside potential for shareholders in January 2026.
Via Barchart.com · January 29, 2026
Should You Buy UnitedHealth Group Stock After Its Steep Sell-Off?fool.com
Tuesday's sell-off in UnitedHealth Group's stock was arguably overdone.
Via The Motley Fool · January 29, 2026
The Road to 7,800: Wall Street Bets on the 'Friendly Policy Mix' to Supercharge the S&P 500
As the first month of 2026 draws to a close, a wave of optimism is sweeping through the equity markets, fueled by a rare alignment of fiscal stimulus, aggressive deregulation, and a structural shift in corporate productivity. Major financial institutions have revised their year-end targets for the S&P 500,
Via MarketMinute · January 28, 2026
Humana's Health Scare Sinks Stock To 9-Year Low. Time To Buy?talkmarkets.com
Humana investors may have suffered cardiac arrest yesterday after shares of the health insurer cratered 21% to close below $208 – the lowest level since early 2017.
Via Talk Markets · January 28, 2026
What's going on in today's session: S&P500 moverschartmill.com
Via Chartmill · January 28, 2026
S&P 500 Shatters Historic 7,000 Milestone as AI Supercycle and Fiscal Stimulus Fuel New Market Era
Wall Street reached a monumental psychological and financial peak on Wednesday as the S&P 500 index briefly eclipsed and then closed near the 7,000-point mark for the first time in history. This breakthrough, occurring on January 28, 2026, represents a staggering 16.6% climb from the 6,000-point
Via MarketMinute · January 28, 2026
Alignment Healthcare (ALHC) Stock Trades Up, Here Is Why
Shares of health insurance company Alignment Healthcare (NASDAQ:ALHC) jumped 4% in the afternoon session after comments from a Baird analyst suggested a promising outlook for earnings growth, helping the stock rebound from a sharp decline in the previous trading session. The recovery followed a significant drop after the Centers for Medicare & Medicaid Services (CMS) released a preliminary payment proposal for Medicare Advantage that fell short of expectations. The agency proposed a mere 0.09% increase in payment rates, which shocked the industry as analysts had projected growth between 4% and 6%. 
Via StockStory · January 28, 2026
These S&P500 stocks have an unusual volume in today's sessionchartmill.com
Via Chartmill · January 28, 2026
These S&P500 stocks are moving in today's sessionchartmill.com
Via Chartmill · January 28, 2026
Jacksonville, FL Health Insurance & Medicare Plans: Comparison Guides Announced
HealthMarkets Insurance Agency addresses growing demand for independent health insurance guidance in Jacksonville with new no-cost consultation services that compare multiple carriers and plan types, helping residents avoid coverage gaps and enrollment penalties while selecting policies suited to their healthcare and financial needs.
Via Press Release Distribution Service · January 28, 2026
UnitedHealth Group Shares Crater 20% as CMS Shocks Market with Near-Zero Medicare Rate Increase for 2027
In a historic blow to the managed care sector, UnitedHealth Group (NYSE: UNH) saw its stock price plunge nearly 20% on Tuesday, marking its worst single-day performance in over three decades. The massive selloff, which erased approximately $80 billion in market value, was triggered by a surprisingly lean 2027 Advance
Via MarketMinute · January 28, 2026
Elevance Health (ELV) Deep-Dive: Navigating the 2026 Regulatory Storm and the Carelon Transformation
Today’s Date: January 28, 2026 Introduction Elevance Health, Inc. (NYSE: ELV) stands at a critical crossroads in the healthcare landscape of 2026. Once known primarily as a regional Blue Cross Blue Shield insurer, the company has transformed into a diversified health services behemoth. However, as of late January 2026, the company is navigating one of [...]
Via Finterra · January 28, 2026